Creative Biolabs offers a comprehensive gut microbiota-based diagnostics platform designed to support biomarker discovery, disease diagnosis, and microbiome-driven research. Leveraging advanced technologies such as next-generation sequencing, mass spectrometry, and multi-omics analysis, the platform enables accurate profiling of gut microbial communities and identification of disease-associated microbiome signatures.
Key Points:
- Multi-omics capabilities: genomics, transcriptomics, proteomics, metabolomics
- Advanced technologies including NGS, mass spectrometry, and immunoassays
- Supports microbiome profiling, signature identification, and bioinformatics analysis
- Covers full workflow from sample processing to data interpretation
- Enables research on host–microbiome interactions and disease mechanisms
- Designed for diagnostics development and microbiome-based precision medicine
